[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: In the control group, placebo capsules (Product of Faran Shimi Pharmaceutical Company) were used exactly at the above intervals", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsSecond intervention group: Fentanyl Group (20 people): 1.5 mcg/kg/h fentanyl (Product of Faran Shimi Pharmaceutical Company) is given for 2 hours a day for 5 consecutive days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsFirst intervention group: Morphine group (20 patients): 3 mg of morphine (Product of Faran Shimi Pharmaceutical Company) is given intravenously every 6 hours for 5 days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 818, "treatment_name": "Morphine", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 508, "treatment_name": "Fentanyl", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]